HEMATOLOGICAL CANCERS
Investigational Treatment for Relapsed or Refractory Acute Myeloid Leukemia (AML)
Acute myeloid leukemia, bone marrow, small molecule inhibitor, AXL signaling, FLT3 Signaling
Investigational Treatment for Relapsed or Refractory Acute Myeloid Leukemia (AML)
Acute myeloid leukemia, bone marrow, small molecule inhibitor, AXL signaling, FLT3 Signaling